IL17A and hepatocellular carcinoma: As for the relationship between HCC cells and JAK2/STAT3 pathway, previous studies have demonstrated that interleukin 7 (IL-17) can induce the JAK2/STAT3 signaling pathway via AKT1 to aggravate HCC (14).